- Title
- Progesterone receptor variant increases ovarian cancer risk in BRCA1 and BRCA2 mutation carriers who were never exposed to oral contraceptives
- Creators
- I. B. Runnebaum (Author)S. Wang-Gohrke (Author)D. Vesprini (Author)R. Kreienberg (Author)Henry T. Lynch (Author) - Creighton UniversityR. Moslehi (Author)P. Ghadirian (Author)B. Weber (Author)A. K. Godwin (Author)H. Risch (Author)J. Garber (Author)C. Lerman (Author)O. I. Olopade (Author)W. D. Foulkes (Author)B. Karlan (Author)E. Warner (Author)B. Rosen (Author)T. Rebbeck (Author)P. Tonin (Author)M. P. Dube (Author)D. G. Kieback (Author)S. A. Narod (Author)
- Publication Details
- Pharmacogenetics, Vol.11(7), pp.635-638
- Number of pages
- 635-638
- Identifiers
- 991005931253102656
- Academic Unit
- School of Medicine; Prev. Medicine & Public Health
- Resource Type
- Journal article
Journal article
Progesterone receptor variant increases ovarian cancer risk in BRCA1 and BRCA2 mutation carriers who were never exposed to oral contraceptives
Pharmacogenetics, Vol.11(7), pp.635-638
10/2001
PMID: 11668223
Metrics
6 Record Views